Protein tyrosine phosphatases regulate a myriad of essential subcellular signaling events, yet they remain difficult to study in their native biophysical context. Here we develop a minimally disruptive optical approach to control protein tyrosine phosphatase 1B (PTP1B)-an important regulator of receptor tyrosine kinases and a therapeutic target for the treatment of diabetes, obesity, and cancer-and we use that approach to probe the intracellular function of this enzyme. Our conservative architecture for photocontrol, which consists of a protein-based light switch fused to an allosteric regulatory element, preserves the native structure, activity, and subcellular localization of PTP1B, affords changes in activity that match those elicited by posttranslational modifications inside the cell, and permits experimental analyses of the molecular basis of optical modulation. Findings indicate, most strikingly, that small changes in the activity of PTP1B can cause large shifts in the phosphorylation states of its regulatory targets. 4 insulin, leptin, and epidermal growth factor signaling and participates in a diverse set of spatiotemporally complex signaling processes 17 . PTP1B has two intriguing biophysical traits that make it particularly amenable to optogenetic study: (i) Its catalytically essential WPD loop undergoes cyclic, open-and-close motions that control the rate of phosphotyrosine hydrolysis at the active site 18 , and its C-terminal ⍺7 helix modulates these motions through an allosteric network that extends over 25 Å across the protein (Fig. 1a ). An architecture for photocontrol that makes use of this network could afford changes in activity that preserve interactions between PTP1B and its regulatory targets. (ii) PTP1B undergoes several post-translational modifications outside of its active site that cause modest, yet physiologically influential shifts in its activity (i.e., 1.7-3.1 fold 19, 20 ; Supplementary Table 1 ). An optogenetic construct that affords similar changes in activity could help determine whether or not they-rather than the specific posttranslational modifications that cause them-are sufficient to influence cellular physiology.
INTRODUCTION
The enzymatic phosphorylation of tyrosine residues is centrally important to cellular function. It controls the location and timing of cellular differentiation, movement, proliferation, and death [1] [2] [3] [4] ; its misregulation can cause cancer, diabetes, and neurodegenerative diseases, among other disorders [5] [6] [7] . Methods to control the activity of phosphorylation-regulating enzymes without interfering with their native structure or cellular organization could, thus, enable detailed analyses of the mechanisms by which cells process essential chemical signals 8, 9 .
Optogenetic actuators-genetically encoded proteins that undergo light-induced changes in conformation-provide a powerful means of controlling enzyme activity over time and space.
As protein fusion partners, they have enabled optical manipulation of biomolecular transport, binding, and catalysis with millisecond and submicron resolution 10, 11 . Common strategies to integrate optogenetic actuators into enzymes include (i) attachment near an active site, where they control substrate access 12, 13 , (ii) insertion within a catalytic domain, where they afford activity-modulating structural distortions 14 , and (iii) fusion to N-or C-termini, where they direct subcellular localization 15 or guide domain assembly 16 . These approaches have generated powerful tools for stimulating phosphorylation-mediated signaling networks; unfortunately, their reliance on disruptive structural modifications has tended to limit their use in biochemical studies of native regulatory effects, for example, spatially dependent protein-protein interactions or, more notably, shifts in activity that match, rather than artificially exceed, those caused by posttranslational modifications of an enzyme under study.
Protein tyrosine phosphatase 1B (PTP1B) is an important regulatory enzyme for which minimally disruptive architectures for photocontrol could prove particularly informative. This enzyme, which catalyzes the hydrolytic dephosphorylation of tyrosine residues, helps regulate 6 alanine, which has a high helix propensity 26 ). Stabilizing mutations in the J⍺ helix have amplified DRs of previous LOV2 fusions 25, 27 . Intriguingly, for our chimeras, mutations in the J⍺ helix improved activity, but reduced photosensitivity; several mutations in the A'⍺ and ⍺7 helices, by contrast, increased the DR (Fig. 1c) . Overall, the effects of amino acid substitutions in these two helices were non-additive and reached a maximum DR of 2.2 on 4MUP. We chose a single high-DR chimera-7.1(T406A), termed PTP1BPS-for further study.
We assessed the structural integrity of the PTP1B domain within PTP1BPS by using Xray crystallography to examine its dark-state conformation. Intriguingly, although crystals of PTP1BPS were yellow and turned clear when exposed to blue light-a behavior indicative of the presence of LOV2 12,28 -diffraction data permitted placement and refinement of only PTP1B
( Supplementary Figures 2 and 3 ). Detection of LOV2 was likely impeded by two interrelated crystallographic features: (i) a disordered ⍺7 helix, which is unresolvable in apo structures of PTP1B 29 , and (ii) variability in the orientation of LOV2 within the crystal lattice (Supplementary Note 1). Despite this structural disorder, aligned catalytic domains of PTP1BPS and wild-type PTP1B had a root-mean-square deviation of 0.30 Å (Fig. 1d ). Crystallographic results, thus, suggest that LOV2 does not alter the native conformation of the catalytic domain of PTP1B.
We explored the mechanism of photomodulation by using kinetic assays to examine the influence of LOV2 on PTP1B-mediated catalysis. In brief, we measured the activity of PTP1BPS on p-nitrophenyl-phosphate (pNPP) in the presence and absence of blue light (455 nm), and we used the initial rates to construct dark-and light-state Michaelis-Menten curves (Fig. 1e ). These curves indicate that blue light reduces kcat by 2.5-fold but leaves Km unaltered. Data collected under repeated illumination, in turn, shows that changes in kcat are reversible ( Supplementary   Figure 4c ). The isolated influence of LOV2 on kcat indicates that this photoswitch does not interfere with substrate binding and, importantly, is consistent with a mechanism in which LOV2 allosterically modulates WPD loop motions, which control the rate of hydrolysis 30 .
To assess the maximum achievable DR for our system, we removed the ⍺7 helix of PTP1B; that is, we used an ⍺7-less variant as a model for a maximally photoswitched form of the enzyme. Intriguingly, helix removal lowered kcat by 2.9-fold, suggesting that PTP1BPS has a DR that is 85% of the maximum value for a photoswitch that inhibits catalytic activity by unwinding the ⍺7 helix ( Supplementary Figures 4a-4b ). Importantly, this DR is within the range of DRs of previously developed light-sensitive signaling enzymes used to elicit physiologically relevant cellular responses to optical stimuli (DRs ~1.7-10 12,31 ; Supplementary Table 8 ) and matches physiologically influential changes in activity caused by post-translational modifications of PTP1B that occur outside of its active site (i.e., phosphorylation, proteolysis, and sumoylation, which reduce/enhance PTP1B activity by 1.7-3.1 fold 19, 20 ; Supplementary Table 1 ).
We hypothesized that an optogenetic system that exerts allosteric control over catalytically essential loop motions might-in contrast with a system that competitively inhibits the active site-exhibit a modulatory effect that is independent of substrate size and binding affinity. To test the substrate dependence of PTP1BPS, we measured its DR on pNPP, 4MUP, and a phosphorylated peptide (Fig. 1f ). The DRs for these substrates differed by less than 15% ( Fig.   1g ); this similarity suggests that the magnitude of photocontrol is, in fact, substrate independent.
Biophysical Analysis of Photocontrol. Although we designed our chimeras to exploit conformational changes in the N-terminal A'⍺ helix of LOV2, the results of crystallographic and spectroscopic analyses of this photoswitch indicate that its N-and C-terminal helices work together to transduce conformational changes across the protein 23, 32 . To examine the contribution of both helices to the photoresponse of chimera 7.1, one of our most light-sensitive chimeras, we introduced disruptive mutations (i.e., we added charged residues at buried sites 32, 33 ). For both helices, disruptive mutations reduced light-dependent catalytic activity as effectively as C450M, a "dark state" mutation that prevents the formation of the cysteine adduct in LOV2; complete removal of the J⍺ helix had the same effect ( Fig. 2a ). Our results thus indicate that both A'⍺ and J⍺ helices are necessary for LOV2-mediated control of PTP1B activity.
A previous NMR study of PTP1B dynamics showed that mutations in its L11 loop can disrupt allosteric communication between the ⍺7 helix and WPD loop 29 . To confirm the contribution of allostery to photocontrol, we modified chimera 7.1 with a mutation known to exert such an effect: Y152A/Y153A. This modification reduced DR by ~25%, a disruption distinct from the conservative/beneficial effects of alanine substitutions in the ⍺7 helix ( Fig. 2a ).
The sensitivity of DR to mutations in the L11 loop indicates that the native allosteric network of PTP1B is, indeed, necessary for optogenetic control of its catalytic activity.
We hypothesized that our most photoswitchable chimeras might exhibit large changes in secondary structure between light and dark states-changes that result largely from ordered-todisordered transitions of the A'⍺, J⍺, and ⍺7 helices. To test this hypothesis, we used circular dichroism (CD) spectroscopy to compare optically induced shifts in ⍺-helical content (δ222 = [CD222-dark-CD222-light]/CD222-dark; Fig. 2b ). Intriguingly, changes were large for the chimeras with light-dependent catalytic activities but spanned a range of values for low-DR constructs, (Fig.   2c ). The one-way dependence of DR on δ222 indicates that changes in ⍺-helical conformation are necessary, but not sufficient for photocontrol.
We speculated that chimeras with large changes in ⍺-helical content (δ222) but lightinsensitive catalytic activities (low DRs) might suffer from weak conformational coupling between the LOV2 and PTP1B domains. To study this coupling, we carried out two experiments.
In the first, we examined the thermal recovery of LOV2 from the light state by illuminating PTP1B-LOV2 chimeras with blue light and, subsequently, measuring the return of ⍺-helical content in the dark (Fig. 2d) . A link between the conformation of LOV2 and ⍺-helical content is supported by (i) the sensitivity of δ222 to disruptive mutations in LOV2 and (ii) the insensitivity of δ222 to the catalytic response of PTP1B (that is, activity-modulating structural changes in PTP1B, which presumably differ between high-and low-DR chimeras, do not affect δ222). In the second experiment, we examined the thermal recovery of PTP1B by measuring the return of tryptophan fluorescence in the dark ( Fig. 2e ). A link between the conformation of PTP1B and tryptophan fluorescence is supported by (i) the existence of six tryptophan residues in PTP1B ( Fig. 2f ) and (ii) the insensitivity of recovery kinetics to the removal of W491, the only tryptophan in LOV2 ( Fig. 2g ). Intriguingly, kinetic constants for thermal recovery were higher for ⍺-helical content than for tryptophan fluorescence, an indication that LOV2 reverts to its dark state more quickly than PTP1B. This discrepancy was (i) smallest for PTP1BPS, the highest-DR construct, (ii) moderate for 7.1(G528A/N538E), a construct with an intermediary DR, and (iii) largest for 7.1(I532E), a J⍺-destabilized mutant without light-dependent catalytic activity ( Fig.   2g ). This pattern in recovery kinetics provides direct evidence that strong inter-domain conformational coupling is necessary for photocontrol of PTP1B activity.
Preparation of a Natively Localized Variant of PTP1BPS. Inside the cell, PTP1B
possesses a C-terminal region-a disordered proline-rich domain followed by a short membrane anchor-that localizes it to the endoplasmic reticulum (ER; Fig. 3a ) 34 . To examine the influence of this region on photocontrol, we attached the bulk of it (all but the hydrophobic ER anchor) to the C-terminus of PTP1BPS and assayed the extended chimera in vitro. This construct (PTP1BPS*) exhibited a reduced DR, which was not improved by the addition of stabilizing mutations to the J⍺ helix (Figs. 3b-3c); nonetheless, it remained photoswitchable. A construct with the full-length C-terminus of PTP1B (everything including the ER anchor; PTP1BPS**), in turn, conferred native localization in COS-7 cells (Fig. 3d ).
We completed our characterization of the elongated forms of PTP1BPS by examining the influence of LOV2 on interactions mediated by the disordered C-terminal region. Briefly, we compared the susceptibilities of PTP1B1-405 and PTP1BPS* to inhibition by DPM-1001, an inhibitor that binds preferentially to this region (Supplementary Figure 5 ) 35 . To our surprise, IC50's differed by ~30%; this small difference indicates that LOV2 does not preclude regulatory interactions with the disordered region. Intriguingly, DPM-1001 also binds weakly to the catalytic domain, likely by binding near the ⍺7 helix 36 ; IC50's for PTP1B1-321 and PTP1BPS were, thus, much higher than IC50's for the full-length constructs and exhibited a greater sensitivity to LOV2. The light-sensitive domain may thus, affect weak interactions that occur at its point of attachment (though, this region is not an established target of post-translational modifications).
An Optogenetic Probe for Studying Intracellular Signaling.
To examine the function of PTP1B-LOV2 chimeras in living cells, we sought a genetically encodable sensor for PTP1B activity. Several previously developed sensors for PTKs could plausibly support such a function;
we chose a sensor for Src kinase 37 , an enzyme with an orthogonal activity to PTP1B 38 . This biosensor consists of an SH2 domain, a flexible linker, and a substrate domain (i.e., WMEDYDYVHLQG, a peptide derived from p130cas), all sandwiched between two fluorescent proteins (FPs). Src-mediated phosphorylation of the substrate domain causes it to bind to the SH2 domain, reducing Förster resonance energy transfer between the FPs (FRET; Fig. 4a ); PTP1B-mediated dephosphorylation of the substrate domain, in turn, reverses this effect and increases FRET. To enhance the compatibility of the sensor with the blue light necessary to stimulate LOV2, we replaced CFP and YPet-the original FPs-with mClover3 and mRuby3, which have longer excitation wavelengths 39 . As expected, incubation of the modified sensor with Src reduced FRET and increased the donor/acceptor emission ratio; simultaneous incubation with Src and PTP1B (or Src and EDTA), by contrast, prevented this increase (Figs. 4b).
We began our imaging studies by co-expressing the biosensor with PTP1B-LOV2 chimeras in COS-7 cells. These cells are large and flat and, thus, facilitate imaging of subcellular regions 40 ; previous studies have used them to examine PTP1B-mediated signaling events 41, 42 .
Whole-cell irradiation of cells expressing PTP1BPS with 457 nm light increased the biosensor signal in both the nucleus and cytosol by ~7%, a change larger than the 3-4% increase afforded by the dark-state mutant ( Fig. 4c and Supplementary Figure 6 ); the response of the biosensor in cells expressing PTP1BPS**, by contrast, was nearly imperceptible when compared to the darkstate analogue ( Supplementary Figure 7 ). We note: Our imaging experiments rely on basal Src activity (i.e., we do not overexpress this enzyme). Accordingly, our findings indicate that transient inactivation of PTP1B allows background concentrations of Src to effect a rapid increase in the population of phosphorylated biosensor (other kinases could certainly contribute to this response, but our chosen biosensor is fairly specific for Src 43 ).
Local irradiation of photoswitchable enzymes can permit detailed studies of spatially dependent signaling events and, by minimizing cellular exposure to optical stimuli, reduce the background signal caused by photobleaching 10 . To assess the compatibility of our light-sensitive chimeras with spatiotemporal studies, we used 405-nm light to irradiate 5-µm circular regions within COS-7 cells, and we measured the response of the biosensor (Figs. 4d-4e). In cells expressing PTP1BPS, local irradiation of the cytosol produced a transient spike in donor/acceptor emission ratio within the irradiated region and a modest, smooth increase in signal within a secondary region located far from the first ( Fig. 4e and Supplementary Figure 8) ; both irradiated and secondary regions maintained a similar increase in signal for at least 30 seconds after irradiation. In cells expressing PTP1BPS**, irradiation near the nucleus produced a similar change in signal, while irradiation near the plasma membrane (PM) failed to do so ( Fig. 4e and Supplementary Figures 9-11a ). In all cases, dark-state mutants produced no detectable effect.
Our results thus indicate that localized inactivation of PTP1BPS and nucleus-proximal PTP1BPS** can produce a measurable cell-wide increase in the phosphorylation state of their targets.
The ER is a vesicular network that extends unevenly from the nucleus of the cell. To determine if the reduced activity of PTP1BPS** near the PM results from the low abundance of ER in this region, we used BFP-Sec61β, a genetically encoded ER label 44 , to measure the subcellular distribution of ER. As expected, the fluorescence of 5-µm circular regions located near the PM was 2.7-fold lower than the fluorescence of equivalently sized regions located near the nucleus ( Supplementary Figures 11b-11c ); this discrepancy suggests that the diffuse distribution of PTP1BPS** near the PM limits its activity on membrane-proximal targets.
Cells rely on complex networks of biomolecular interactions to transmit, filter, and integrate chemical signals 45 . The biochemical repercussions of changes in the activity of any single regulatory enzyme are, thus, difficult to assess with artificial biosensors alone. To evaluate the influence of modest changes in PTP1B activity on the phosphorylation state of a native regulatory target, we generated HEK293T/17 cells that stably express PTP1BPS** and used an enzyme-linked immunosorbent assay (ELISA) to measure shifts in IR phosphorylation caused by transient illumination (455 nm, 10 minutes). To our surprise, illumination increased IR phosphorylation to levels that rivaled those elicited by high concentrations of both an allosteric inhibitor (BBR) and insulin ( Fig. 4g ). These optically derived shifts-which, by our best estimate, exceed a twenty-fold increase over background levels (Supplementary Note 2)-did not occur in cells shielded from light or in cells stably expressing PTP1BPS**(C450M); IR phosphorylation levels in these two varieties of cells were indistinguishable from those of the wild-type cell line. Our findings thus suggest that PTP1BPS** leaves native phosphorylation levels intact but enables large shifts in target phosphorylation under blue light.
DISCUSSION
The study of PTPs has long suffered from a paucity of tools for probing and measuring their intracellular activities 46 . In this study, we developed a photoswitchable variant of PTP1B and used it to exert spatiotemporal control over the phosphorylation state of a genetically encoded biosensor in living cells. Transient irradiation of the full-length, natively localized construct near the nucleus but not the PM produced cell-wide changes in sensor phosphorylation. Importantly, the changes in activity afforded by our allosteric control system reach-by our best estimate-70-85% of the maximum achievable dynamic range and match physiologically influential changes in activity caused by post-translational modifications of PTP1B inside the cell ( Supplementary Table 1 ). Our analysis of IR phosphorylation, in turn, suggests that modest changes in the activity of PTP1B are sufficient to effect large shifts (i.e., over twenty-fold) in the phosphorylated fraction of its regulatory targets. This result, which evidences an intriguing sort of hypersensitivity, indicates that our photoswitchable PTP1B-which unlike PTP inhibitors 47 , offers both exquisite selectivity and spatiotemporal precision-could provide a useful tool for biochemical analyses that rely on precise, protein-specific perturbations (e.g., imaging studies and proteomic analyses) 48 . PTP1B is a therapeutic target for the treatment of diabetes, obesity 49 , breast cancer 50 , and cardiovascular disease 51 , and has emerged as a potential modulator of inflammation 52 , anxiety 53 , immunity 54 , memory 55 , and neural specification in embryonic stem cells 56 ; by facilitating detailed analyses of the contribution of PTP1B to these complex processes, the tools developed in this study could help to elucidate the biochemical basis-and, perhaps, shared origin-of a diverse set of physiological states.
Classical-or tyrosine-specific-PTPs possess several features that are particularly incompatible with conventional approaches to optical control: Their solvent-exposed active sites are distal to both termini and, thus, difficult to obstruct with light-sensitive fusion partners 57 ; they engage in protein-protein interactions at delocalized-and incompletely mapped-surface sites that make the physiological repercussions of domain insertion (or domain dissection) difficult to assess [58] [59] [60] ; and their subcellular localization affects regulatory function in a nonbinary manner that complicates the use of optically induced re-localization to study cell signaling 41, 61 . Accordingly, future efforts to use these methods to build photoswitchable PTPs could be worthwhile-and may yield constructs with higher DRs than those described in this study; accompanying analyses of the influence of new control systems on protein structure, activity, and/or subcellular localization, however, will facilitate a detailed assessment of their benefits over the present system.
The results of this work offer two general insights for the design of genetically encoded probes. First, kinetic assays of PTP1BPS demonstrate that allosteric systems for photocontrol can-at least, within some classes of proteins-effect isolated changes in kcat; such designs may be less disruptive to substrate binding (i.e., more substrate agnostic) than systems in which light-sensitive domains act as competitive inhibitors (which can be outcompeted by a sufficiently high concentrations of substrate). Future analyses of differences in the intracellular concentrations and binding affinities of regulatory targets will clarify the extent of this benefit. Second, spectroscopic analyses of PTP1B-LOV2 chimeras provide experimental evidence that strong interdomain conformational coupling can enhance allostery-derived photocontrol of one domain with another. Computational methods to optimize this coupling (e.g., methods that enhance correlated motions between fused domains or that reduce the dissipation of energy between them) could, thus, facilitate the development of new-and, perhaps, protein-specific-varieties of minimally disruptive control systems.
METHODS
Cloning and molecular biology. We constructed PTP1B-LOV2 chimeras by fusing PTP1B and LOV2 at crossover points in a primary sequence alignment. In brief, we used EMBOSS Needle, an implementation of the Needleman-Wunsch algorithm 62 , to align the Cterminus of PTP1B (residues 285-305) with the N-terminus of LOV2 (residues 387-410), and we selected eight matching aligned residues as fusion points for the two domains ( Fig. 1b) . To assemble chimeric genes, we amplified DNA encoding PTP1B and LOV2 from pET21b and pTriEx-PA-Rac1 plasmids, respectively. (The pET21b plasmid was a kind gift from the Tonks Group of Cold Spring Harbor Laboratory; we purchased pTriEx-PA-Rac1 from Addgene). We joined the two amplified segments with overlap extension PCR (oePCR; see Supplementary   Table 3 for primers) and ligated the final chimeric product into pET16b for protein expression.
We generated additional constructs with standard techniques. To build single-site mutants and truncation variants, we amplified parent plasmids with appropriate mutagenic primers ( Supplementary Table 4 ). To construct PTP1BPS* and PTP1BPS**, we amplified C-terminal regions of PTP1B (residues 299-405 and 299-435, respectively) from pGEX-2T-PTP1B (Addgene) and used Gibson assembly to join them to the C-terminus of PTP1BPS (50°C for 1 hr;
see Supplementary Table 5 for primers). Finally, to construct GFP-tagged versions of PTP1BPS, PTP1BPS**, and PTP1B435, we amplified these genes from their parent plasmids (see Supplementary Table 5 for primers) and ligated the PCR product into pAcGFP1-C1 (Clonetech, Inc.) at the NcoI and BamHI sites of the MCS for protein expression.
We developed a biosensor for PTP1B by replacing the fluorescent proteins of a biosensor for Src kinase 37 with mClover3 and mRuby3 39 . In brief, we amplified DNA encoding the following components: (i) the central segment of the Src biosensor-the SH2 domain, interdomain linker, and substrate domain (i.e., WMEDYDYVHLQG, a peptide derived from p130cas)-from its parent plasmid (a Kras-Src FRET biosensor, Addgene), (ii) genes for mClover3 and mRuby3 (plasmids pNCS-mClover3 and pNCS-mRuby3, respectively), and (iii) the backbone of pAcGFP1-C1 (Clonetech, Inc.). After amplification, we joined all segments with Gibson assembly (50°C for 1 hr; see Supplementary Table 6 for primers).
For live-cell studies, we integrated the modified biosensor and PTP1B-LOV2 chimeras into pAcGFP1-C1 by using protocols described above. In short, we amplified DNA encoding (i) PTP1BPS or PTP1BPS**, (ii) a ribosomal skipping peptide sequence (P2A-GSG, GSGATNFSLLKQAGDVEENPGP), (iii) the modified biosensor, and (iv) the pAcGFP1-C1 backbone, and we joined the segments with Gibson assembly (50°C for 1 hr; see Supplementary   Tables 6 and 7 for primers and DNA fragments, respectively).
Protein expression and purification. We overexpressed PTP1B1-281, PTP1B1-321, PTP1B1-405, LOV2404-547-, PTP-LOV2 chimeras, Src251-536, and the modified biosensor in E. coli by carrying out the following steps: (i) We subcloned 6x polyhistidine-tagged versions of each construct into a pET16b plasmid. We positioned the tag at the N-terminus of Src and the FRETbased biosensor and the C-terminus for all other proteins. For Src, we also added a gene for Cdc37, a chaperone that facilitates protein folding in bacteria 63 Initial analysis of photoswitching. We screened PTP-LOV2 chimeras for light-dependent catalytic activity by measuring their activity on 4MUP in the presence and absence of light. In brief, we carried out the following steps: (i) In a room illuminated with a red light (625 nm), we prepared two 96-well plates-hereafter referred to as the "light plate" and "dark plate"-with 100-μL reactions consisting of buffer (50 mM HEPES, 0.5 mM TCEP, pH 7.5), substrate (500 μM 4MUP), and enzyme (5 nM); we added a plastic cover to each plate. (ii) We encased the dark plate in foil and placed the light plate in a chamber made up of two opposing reflective steel bowls fed with a 455-nm light (~450 mW, SLS-0301-C, Mightex Systems, Inc.; Supplementary   Figures 1d-1f ). (iii) We incubated both plates at room temperature (~22°C). (iv) At 7, 14, 21, 28, 35 and 42 minutes after beginning the reaction, we removed each plate from its resting position (i.e., the foil cover or light chamber), loaded it into a SpectraMax M2 plate reader, and measured the formation of 4-methylumbelliferone (365ex/450em); we immediately returned each plate to its resting position. (v) We used discrete measurements to estimate initial rates and, thus, to calculate DR (i.e., Vo-dark/Vo-light).
We minimized error in our measurements of photoswitching with four precautions: (i)
We used concentrations of enzyme and substrate that sustained initial reaction rates for 42 minutes, a length of time that minimizes the disruption of 1-min breaks required to measure product formation. (ii) For each construct in each plate, we prepared two sets of three compositionally identical, yet differentially positioned wells; this arrangement minimizes potential contributions from nonuniform illumination. (iii) For each construct at each illumination condition, we repeated the assay at least three times, collecting a total six estimates of initial rate, each based on measurements from three wells. (iv) We established a control range:
When wild-type PTP1B, which was present in each plate, exhibited a 10% difference in activity between the two plates, we discarded data from both (i.e., we assumed that differences in activity between the two plates were not caused by the presence or absence of light).
We examined the light-dependent catalytic activity of PTP1BPS on a phosphopeptide (DADEpYLIPQQG from EGFR) by following the aforementioned procedure with several differences: (i) We used a substrate concentration of 120 µM and a total reaction volume of 40 uL. (ii) We added malachite green solution (Sigma-Aldrich) to stop individual reactions at 2, 4, 6, or 8 minutes. (iii) We measured the formation of phosphate by using the plate reader to quantify a complex formed between orthophosphate, molybdate, and Malachite Green (620abs); we waited until the end of our experiments (i.e., 8 minutes) for all absorbance measurements. We note: the statistically indistinguishable DRs (p < 0.01, two-tailed Student's t test) determined for PTP1BPS on substrates that require different spectrophotometric measurements (i.e., fluorescence 20 at 450 nm for 4MUP and absorbance at 620 nm for a phosphopeptide) suggest that the illumination conditions used for optical measurement do not artificially depress or enhance DR.
Enzyme kinetics. We examined the influence of photomodulation on enzyme kinetics by measuring the activities of PTP1BPS and PTP1BPS* on pNPP in the presence and absence of light (i.e., we used dark and light plates as described above). Briefly, we prepared 100-μL reactions Finally, we evaluated the reversibility of our LOV2-based light switch by illuminating 25 uM of PTP1BPS (50 mM HEPES, 0.5 mM TCEP, pH 7.5) for 10 seconds and by, subsequently, monitoring its activity on 5 mM pNPP after 5 minutes in the dark. To minimize error, we repeated this experiment three times with seven cycles per experiment ( Supplementary Figure 2 ). X-ray crystallography. We prepared crystals of PTP1BPS by using hanging drop vapor diffusion. To begin, we prepared a concentrated solution of PTP1BPS (~400 μM PTP1BPS, 50 mM HEPES, pH 7.3) and a crystallization solution (100 mM HEPES, 200 mM magnesium acetate, and 14% polyethylene glycol 8000, pH 7.5); we mixed the two solutions in 1:2, 1:3, and 1:6 ratios (protein: crystallization) to form 7-9 μl droplets for crystal growth; and we incubated the droplets over reservoirs filled with crystallization solution at 4℃ in the dark. Long hexagonal crystals with a yellow hue appeared after 1-3 weeks. Prior to freezing, we soaked all crystals in cryoprotectant (100 mM HEPES, 200 mM magnesium acetate, and 25% polyethylene glycol 8000, pH 7.5) overnight.
We collected X-ray diffraction through the Collaborative Crystallography Program of the Berkeley Center for Structural Biology. We performed integration, scaling, and merging of XRD data with the xia2 software package, and we carried out molecular replacement with the Phenix graphical user interface, followed by one round of PDB-REDO 65 . The crystallographic data collected in this study are reported in Table 1 .
Circular dichroism spectroscopy.
We examined the influence of photomodulation on the secondary structure of PTP1B-LOV2 chimeras by using a circular dichroism spectrophotometer (Applied Photophysics Chirascan Plus) to measure optically induced changes in ⍺-helical content. To collect full-spectrum measurements, we incubated 0.2 g/L solutions of each chimera (10 mM NaPi, 0.5 mM TCEP, pH 7.5) in a crystal cuvette (0.05-cm path length) for 10 seconds with/without blue light (455 nm) and immediately measured mean residue ellipticity (MRE) at 1nm increments from 185 to 260 nm. To measure thermal recovery, we began as before, but we measured MRE at 222 nm every 2.5 seconds for 250 seconds in the dark. We normalized the CD data thus gathered with Eq. 1, where CDt, CD0, CD250 represent MRE at t, 0, and 250 (Eq. 1) (Eq. 2) seconds; and we fit the normalized data to an equation for exponential decay (Eq. 2). Final values of k reflect the mean and standard error of values determined from fits to six data sets.
Fluorescence spectroscopy. To examine the influence of photomodulation on the conformation of PTP1B within PTP1B-LOV2 chimeras, we use fluorescence spectroscopy to measure optically induced changes in tryptophan fluorescence. In brief, we prepared 60 µM solutions of protein (50 mM HEPES, 0.5 mM TCEP, pH 7.5) in a Helma ultra-micro quartz cuvette (Thomas Scientific, Inc.); we illuminated those solutions for 10 seconds with a 455-nm light; and we monitored fluorescence (280ex/365em) in 10-second intervals for 200 seconds using a SpectraMax M2 plate reader. We normalized the fluorescence data, thus gathered, with Eq. 3, where Wt, W0,
W250 represent the emission at t, 0, and 250 seconds; and we fit the normalized data to an equation for exponential decay (Eq. 4). Final values of k reflect the mean and standard error of values determined from fits to six datasets.
Biosensor development. We assessed the sensitivity of an Src biosensor 37 to the activity of PTP1B by incubating it with Src in the presence and absence of PTP1B. We prepared 100-μL reactions consisting of 2 µM biosensor and 300 nM Src kinase in 1X kinase buffer A (Thermo Fisher Scientific, Inc.) supplemented with 2 mM DTT, 2 mM MgCl2, and 50 µM ATP. For a subset of reactions, we added PTP1B and EDTA at concentrations of 100 nM and 50 mM, respectively. For each reaction, we monitored the fluorescence of mClover3 (475ex/520em) and mRuby3 (475ex/600em nm) in 10-min increments for 300 minutes on a Spectramax M2 plate reader. The 488-nm light used to image our FRET-based biosensor could plausibly stimulate LOV2, which absorbs at 488 nm (although less so than at 405 and 457 nm) 66 . The results of reagent (Invitrogen) according to the manufacturer's protocols. We passaged the cells in our growth media (as above) supplemented with 1.5 µg/mL puromycin, and we replaced the media every day for 10 days. We passaged the cells 7 times before freezing them for further use.
Enzyme-linked immunosorbent assay (ELISA) of insulin receptor phosphorylation.
We examined IR phosphorylation in HEK293T/17 cells exposed to various conditions by using an enzyme-linked immunosorbent assay (ELISA). To begin, we used siRNA to deplete cells of endogenous PTP1B (see above) and starved them for 48 hours with FBS-free media. After starvation, we exposed cells to one of several conditions for 10 minutes: crystal structure of PTP1B (pdb entry 2f71) shows the locations of six tryptophan residues (blue) 40 and the WPD loop (yellow). g, Kinetic constants for thermal recovery are larger for α-helical content than for tryptophan fluorescence (the latter of which is not affected by W491). The discrepancy between these constants is smallest for PTP1BPS (i.e., 7.1(T406A)). The plotted data depict the mean, associated data points, and SE for n = 6 independent reactions. Source data are provided as a Source Data file. 
